EUVIMEDEUVIMED entdecken
Open Access

Seroprevalence of anti-SARS-CoV-2 IgG antibodies among vaccinated healthcare workers in Bamako, Mali

Etienne Dembele, Yacouba Cissoko, Anou M Somboro, Aichata Dembele, Josue Togo, Djibril M Bah, Issiaka Camara, Ousmane Kodio, Mohamed Tolofoudie, Bourahima Kone, Antieme Cg Togo, Bocar Baya und 7 weitere

African Health Sciences · 2025

DOI: 10.4314/ahs.v25i3.4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift African Health Sciences, 2025. Verfasst von Etienne Dembele und 18 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control (CDC) Georgia, USA. Hauptthemen laut MEDLINE: Immunoglobulin G, Health Personnel, SARS-CoV-2, COVID-19. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Like many other countries, Mali, a West African country, has encountered various obstacles in the fight against the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite resource constraints, however, the country implemented containment strategies. Therefore, in early 2021, Mali initiated a vaccination campaign as a tangible defense against COVID-19, prioritizing the administration of the first vaccine doses to healthcare personnel. Consequently, we found assessing anti-SARS-CoV-2 IgG antibody levels important to gauge the efficacy of vaccines administered to frontline healthcare workers in Bamako, Mali.

Methods

The study enrolled 172 vaccinated front-line healthcare workers from referral hospitals in Bamako, Mali, between March and June 2022. Serum samples were subjected to enzyme-linked immunosorbent assay (ELISA) to assess the levels of anti-SARS-CoV-2 IgG antibodies. Prevaccination serum samples served as controls. Chi-square and Mann-Whitney tests were used to compare proportions and means.

Results

Among the 172 participants, 98.2% had high levels of anti-SARS-CoV-2 spike protein antibodies; only 1.6% (n=2) were seronegative. The majority, 62.2% (n=107), received a two-dose vaccination schedule, and the Astra Zeneca® vaccine was the most widely used (52.3%). The average level of postvaccine antibodies was significantly greater in participants who received two doses of vaccine than in those who received one dose (33.7 index vs. 29.1 index; p=0.02).

Conclusions

Most healthcare workers exhibited favorable vaccine responses, as indicated by their positive reactivity to anti-SARS-CoV-2 IgG spike proteins. The nature and dosage of the vaccines influenced the antibody response, with a notable advantage observed for individuals who received a two-dose regimen. These findings underscore the importance of continuous research and evaluation to understand and enhance vaccine effectiveness. Keywords: COVID-19 vaccines; SARS-CoV-2 seroprevalence; healthcare workers; Bamako; Mali.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GHealth PersonnelSARS-CoV-2COVID-19Antibodies, ViralCOVID-19 VaccinesHumansMaliFemaleMaleAdultSeroepidemiologic StudiesMiddle AgedEnzyme-Linked Immunosorbent AssayVaccinationYoung Adult

Stichwörter der Autor:innen

BamakoCOVID-19 vaccinesMaliSARS-CoV-2 seroprevalencehealthcare workers

Substanzen

Immunoglobulin GAntibodies, ViralCOVID-19 Vaccines

Autor:innen und Institutionen

  • Centers for Disease Control (CDC) Georgia, USA.
  • Institute for Global Health, Northwestern University, Chicago, Illinois, USA.
  • University Clinical Research Center (UCRC) Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Department of Infectious Diseases and Tropical Medicine, Point "G" University Teaching Hospital, Bamako, Mali.
  • Antimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.
  • Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Dembele, E., Cissoko, Y., Somboro, A. M., Dembele, A., Togo, J., Bah, D. M., Camara, I., Kodio, O., Tolofoudie, M., Kone, B., Togo, A. C., Baya, B., Diarra, B., Sarro, Y. D. S., Murphy, R. L., Maiga, A. I., Holl, J. L., Maiga, M., & Dao, S. (2025). Seroprevalence of anti-SARS-CoV-2 IgG antibodies among vaccinated healthcare workers in Bamako, Mali. African Health Sciences. https://doi.org/10.4314/ahs.v25i3.4

Vancouver

Dembele E, Cissoko Y, Somboro AM, Dembele A, Togo J, Bah DM, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies among vaccinated healthcare workers in Bamako, Mali. African Health Sciences. 2025. doi:10.4314/ahs.v25i3.4

BibTeX
@article{Dembele2025,
  author = {Dembele, Etienne and Cissoko, Yacouba and Somboro, Anou M and Dembele, Aichata and Togo, Josue and Bah, Djibril M and Camara, Issiaka and Kodio, Ousmane and Tolofoudie, Mohamed and Kone, Bourahima and Togo, Antieme Cg and Baya, Bocar and Diarra, Bassirou and Sarro, Yeya Dit Sadio and Murphy, Robert L and Maiga, Almoustapha I and Holl, Jane L and Maiga, Mamoudou and Dao, Sounkalo},
  title = {Seroprevalence of anti-SARS-CoV-2 IgG antibodies among vaccinated healthcare workers in Bamako, Mali},
  journal = {African Health Sciences},
  year = {2025},
  doi = {10.4314/ahs.v25i3.4}
}
Kostenlos starten →